UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Utility of voriconazole therapeutic drug monitoring: a meta-analysis

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1786-1799

2016

Link zum Volltext

Verfügbarkeit prüfen

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1772-1785

2016

Link zum Volltext

Verfügbarkeit prüfen

Steady-state pharmacokinetics and metabolism of voriconazole in patients

Journal of antimicrobial chemotherapy, 2013-11, Vol.68 (11), p.2592-2599

2013

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole metabolism is influenced by severe inflammation: a prospective study

Journal of antimicrobial chemotherapy, 2017-01, Vol.72 (1), p.261-267

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (suppl_1), p.i12-i18

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim

Journal of antimicrobial chemotherapy, 2022-05, Vol.77 (6), p.1645-1654

2022

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1118-1122

2017

Link zum Volltext

Verfügbarkeit prüfen

Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis

Journal of antimicrobial chemotherapy, 2016-11, Vol.71 (11), p.3135-3147

2016

Link zum Volltext

Verfügbarkeit prüfen

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

Journal of antimicrobial chemotherapy, 2014-06, Vol.69 (6), p.1633-1641

2014

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.2031-2036

2016

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2234-2240

2016

Link zum Volltext

Verfügbarkeit prüfen

Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model

Journal of antimicrobial chemotherapy, 2020-01, Vol.75 (1), p.140-148

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone

Journal of antimicrobial chemotherapy, 2019-01, Vol.74 (1), p.228-233

2019

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen

Journal of antimicrobial chemotherapy, 2017-06, Vol.72 (6), p.1709-1713

2017

Link zum Volltext

Verfügbarkeit prüfen

Do high MICs predict the outcome in invasive fusariosis?

Journal of antimicrobial chemotherapy, 2021-03, Vol.76 (4), p.1063-1069

2021

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods

Journal of antimicrobial chemotherapy, 2023-03, Vol.78 (3), p.817-822

2023

Link zum Volltext

Verfügbarkeit prüfen

Changing epidemiology of candidaemia in Australia

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1103-1108

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring and use of an adjusted body weight strategy for high-dose voriconazole therapy

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1178-1183

2017

Link zum Volltext

Verfügbarkeit prüfen

Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort

Journal of antimicrobial chemotherapy, 2015-04, Vol.70 (4), p.1161-1165

2015

Link zum Volltext

Verfügbarkeit prüfen

Exploring synergy between azole antifungal drugs and statins for Candida auris

Journal of antimicrobial chemotherapy, 2023-12, Vol.78 (12), p.2824-2829

2023

Link zum Volltext

Verfügbarkeit prüfen

Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.815-820

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms

Journal of antimicrobial chemotherapy, 2023-04, Vol.78 (4), p.1076-1083

2023

Link zum Volltext

Verfügbarkeit prüfen

Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML

Journal of antimicrobial chemotherapy, 2015-11, Vol.70 (11), p.3124-3126

2015

Link zum Volltext

Verfügbarkeit prüfen

Invasive mould infections in the ICU setting: complexities and solutions

Journal of antimicrobial chemotherapy, 2017-03, Vol.72 (suppl_1), p.i39-i47

2017

Link zum Volltext

Verfügbarkeit prüfen

Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1908-1911

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Zeitschrift / SerieJournal Of Antimicrobial Chemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(53)
Life Sciences & Biomedicine
(53)
Microbiology
(53)
Pharmacology & Pharmacy
(53)
Science & Technology
(53)
Humans
(46)
Antifungal Agents - Pharmacology
(24)
Voriconazole
(23)
Antifungal Agents - Therapeutic Use
(19)
Microbial Sensitivity Tests
(18)
Female
(17)
Voriconazole - Pharmacology
(17)
Male
(16)
Antifungal Agents - Administration & Dosage
(15)
Antifungal Agents - Pharmacokinetics
(15)
Middle Aged
(14)
Pharmacology
(14)
Voriconazole - Therapeutic Use
(14)
Fungal Infections
(13)
Aspergillosis - Drug Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Utility of voriconazole therapeutic drug monitoring: a meta-analysis

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Steady-state pharmacokinetics and metabolism of voriconazole in patients

Voriconazole metabolism is influenced by severe inflammation: a prospective study

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations

Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim

Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis

Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model

Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen

Do high MICs predict the outcome in invasive fusariosis?

In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods

Changing epidemiology of candidaemia in Australia

Therapeutic drug monitoring and use of an adjusted body weight strategy for high-dose voriconazole therapy

Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort

Exploring synergy between azole antifungal drugs and statins for Candida auris

Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit

Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms

Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML

Invasive mould infections in the ICU setting: complexities and solutions

Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England

Aktive Filter

Suchergebnisse filtern